BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Becker L, Verdurmen WPR, Plückthun A. Reengineering anthrax toxin protective antigen for improved receptor-specific protein delivery. BMC Biol 2020;18:100. [PMID: 32792013 DOI: 10.1186/s12915-020-00827-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ruschig M, Marschall ALJ. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context. BioDrugs 2023;37:181-203. [PMID: 36729328 DOI: 10.1007/s40259-023-00580-y] [Reference Citation Analysis]
2 Lu J, Xiao Z, Xu M, Li L. New Insights into LINC00346 and its Role in Disease. Front Cell Dev Biol 2021;9:819785. [PMID: 35096842 DOI: 10.3389/fcell.2021.819785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Uribe KB, Guisasola E, Aires A, López-Martínez E, Guedes G, Sasselli IR, Cortajarena AL. Engineered Repeat Protein Hybrids: The New Horizon for Biologic Medicines and Diagnostic Tools. Acc Chem Res 2021. [PMID: 34730945 DOI: 10.1021/acs.accounts.1c00440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Becker L, Singh Badwal J, Brandl F, Verdurmen WPR, Plückthun A. Thermodynamic Stability Is a Strong Predictor for the Delivery of DARPins to the Cytosol via Anthrax Toxin. Pharmaceutics 2021;13:1285. [PMID: 34452246 DOI: 10.3390/pharmaceutics13081285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Liu W, Nestorovich EM. Anthrax toxin channel: What we know based on over 30 years of research. Biochim Biophys Acta Biomembr 2021;1863:183715. [PMID: 34332985 DOI: 10.1016/j.bbamem.2021.183715] [Reference Citation Analysis]
6 Torres C, Dumas S, Palacio-Castañeda V, Descroix S, Brock R, Verdurmen WPR. A Computational Investigation of In Vivo Cytosolic Protein Delivery for Cancer Therapy. Pharmaceutics 2021;13:562. [PMID: 33921165 DOI: 10.3390/pharmaceutics13040562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Piot N, van der Goot FG, Sergeeva OA. Harnessing the Membrane Translocation Properties of AB Toxins for Therapeutic Applications. Toxins (Basel) 2021;13:36. [PMID: 33418946 DOI: 10.3390/toxins13010036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]